Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients

NCT05688332 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus Type 2 Without Complication

Interventions

DRUG: Voglibose + Metformin
DRUG: Glibenclamide + Metformin

Sponsor

University of Zambia

Collaborators

[object Object]